Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 168
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
MindMed Announces Compliance with Nasdaq Listing Requirements
MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE...
Sep 13, 2022, 16:50 ETMINDCURE Announces Financial Results for Fiscal 2022VANCOUVER,...
Psilera Receives First Patent Allowance for Transdermal Patch Formulations
Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of...
Revive Therapeutics Announces Submission of Amended Phase 3 COVID-19 Study Protocol...
Small Pharma Enters Into Automatic Share Purchase Plan
Numinus provides update on acquisition integration and announces new client financing...
Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up
PT355 – Ifetayo Harvey – The Drug War, Caregiving, and Blue...
Load more